| Name | |
| Saponins 10% | |
| Specifications | |
| Botanical name: Momordica
Charantica L. Parts used: Fruit Active compounds: At least three different groups of constituents in bitter melon have been reported to have hypoglycemic (blood sugar lowering) or other actions of potential benefit in diabetes mellitus. These include a mixture of steroidal saponins known as charantin, insulin-like peptides, and alkaloids. It is still unclear which of these is most effective or if all three work together. Two proteins, known as alpha- and beta-momorcharin, inhibit the AIDS virus. An as yet unidentified constituent in bitter melon inhibits the enzyme guanylate cyclase, that may benefit people with psoriasis. Extract method: By hydro-alcohol extraction. Specification: Total Saponins: 10%£¡§HPLC£© Moisture£º¡Ü5% Ash£º¡Ü 4% Solvent£º¡Ü0.01% Heavy Metals£º¡Ü10ppm As£º¡Ü1ppm Pesticides residue£ºAbsent Functions: A relatively common food item, bitter melon was traditionally used for a dazzling array of conditions by people. Numerous infections, cancer, leukemia, and diabetes are among the most common conditions it was believed to improve. Bitter melon is reported to help in the treatment of: Diabetes HIV support Psoriasis The blood lowering action of the fresh juice of the unripe bitter melon has been confirmed in scientific studies in animals and humans. Charantin is more powerful than the drug tolbutamide, which is sometimes used in the treatment of diabetes to lower the blood sugar levels. The ripe fruit of bitter melon has been shown to exhibit some remarkable anticancer effects, especially leukemia. |
|